Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMCC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TRMT11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDUFAF7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FDX1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LIMA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LMBR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLPB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARNTL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GALE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MANEAL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CSRNP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPFIBP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HEBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM98C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IRF5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AZGP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHCHD7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on